The effect of portulaca oleracea alkaloids on antidiabetic properties through changes in ceramide metabolism

References

• Roozi H, Bojar MA, Eidi V, et al. Effects of oleracein E and oleracein L from portulaca oleracea on cell survival, antioxidant and antidiabetic efficacy on beta-TC-6 pancreatic cell line. Indian J Pharm Sci. 2019;81(4):681–689.
   Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2019;81(4):546.
   Google Scholar
• Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013;9(1):25–53.
   PubMedGoogle Scholar
• Huang Q, Chen L, Teng H, et al. Phenolic compounds ameliorate the glucose uptake in HepG2 cells' insulin resistance via activating AMPK: anti-diabetic effect of phenolic compounds in HepG2 cells. Journal of Functional Foods. 2015;19:487–494
   Web of Science ®Google Scholar
• Beisswenger PJ, Moore LL, Brinck-Johnsen T, et al. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest. 1993;92(1):212–217.
   Web of Science ®Google Scholar
• Nowotny K, Jung T, Höhn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222.
   PubMed Web of Science ®Google Scholar
• Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res. 2006;45(1):42–72.
   PubMed Web of Science ®Google Scholar
• Boojar MMA, Hassanipour M, Mehr SE, et al. New aspects of silibinin stereoisomers and their 3-O-galloyl derivatives on cytotoxicity and ceramide metabolism in Hep G2 hepatocarcinoma cell line. Iran J Pharm Res. 2016;15(3):421.
   Web of Science ®Google Scholar
• Galadari S, Rahman A, Pallichankandy T, et al. Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis. 2013;12(1):98.
   PubMed Web of Science ®Google Scholar
• Haus JM, Kashyap SR, Kasumov S, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009;58(2):337–343.
   PubMed Web of Science ®Google Scholar
• Boojar MA, Masoud Mashhadi Akbar Boojar M, Golmohammad S. Ceramide pathway: a novel approach to cancer chemotherapy. Egypt J Basic Appl Sci. 2018;5(4):237–244.
   Google Scholar
• Kooti W, Farokhipour M, Asadzadeh Z, et al. The role of medicinal plants in the treatment of diabetes: a systematic review. Electron Physician. 2016;8(1):1832. .
   PubMedGoogle Scholar
• Karimi G, Alireza A, Abbas O, et al. Protective effect of aqueous and ethanolic extracts of Portulaca oleracea against cisplatin induced nephrotoxicity. Iran J Basic Med Sci. 2010;13(2):31–35.
   Web of Science ®Google Scholar
• Zhou Y-X, Xin H-L, Rahman K, et al. Portulaca oleracea L.: a review of phytochemistry and pharmacological effects. Biomed Res Int. 2015; 2015. doi:https://doi.org/10.1155/2015/925631
   Google Scholar
• Xiang L, Wang W, Wang R-F, et al. Alkaloids from Portulaca oleracea L. Phytochemistry. 2005;66(21):2595–2601.
   PubMed Web of Science ®Google Scholar
• Chen T, Wang J, Li Y, et al. Sulfated modification and cytotoxicity of Portulaca oleracea L. polysaccharides. Glycoconj J. 2010;27(6):635–642.
   PubMed Web of Science ®Google Scholar
• Dong C-X, Hayashi K, Lee J-B, et al. Characterization of structures and antiviral effects of polysaccharides from Portulaca oleracea L. Chem Pharm Bull. 2010;58(4):507–510.
   Web of Science ®Google Scholar
• Zidan Y, Bouderbala S, Djellouli F, et al. Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholesterol diet. Phytomedicine. 2014;21(12):1504–1508.
   Web of Science ®Google Scholar
• Pakdel R, Niazmand S, Mouhebati M, et al. A comparison between the effects of Portulaca oleracea seeds extract and valsartan on echocardiographic and hemodynamic parameters in rats with levothyroxine-induced thyrotoxicosis. Avicenna J Phytomed. 2018;8(3):276.
   Web of Science ®Google Scholar
• Lei Q, Liu H, Peng Y, et al. In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleayacordata (Bo Luo Hui). Chin Med. 2015;10(1):37.
   Web of Science ®Google Scholar
• Sun H, He X, Liu C, et al. Effect of Oleracein E, a neuroprotective tetrahydroisoquinoline, on rotenone-induced Parkinson’s disease cell and animal models. ACS Chem Neurosci. 2017;8(1):155–164. .
   Web of Science ®Google Scholar
• Jiao -Z-Z, Yue S, Sun H-X, et al. Indoline Amide glucosides from portulaca oleracea : isolation, structure, and DPPH radical scavenging activity. J Nat Prod. 2015;78(11):2588–2597. .
   PubMed Web of Science ®Google Scholar
• Henle T, Schwarzenbolz U, Klostermeyer H. Detection and quantification of pentosidine in foods. Zeitschrift für Lebensmitteluntersuchung und-Forschung A. 1997;204(2):95–98.
   Web of Science ®Google Scholar
• He X, Dagan A, Gatt S, et al. Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase. Anal Biochem. 2005;340(1):113–122. .
   PubMed Web of Science ®Google Scholar
• Morad SAF, Levin JC, Tan S-F, et al. Novel off-target effect of tamoxifen—inhibition of acid ceramidase activity in cancer cells. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2013;1831(12):1657–1664.
   Web of Science ®Google Scholar
• Hojjati MR, Jiang X-C. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res. 2006;47(3):673–676.
   Web of Science ®Google Scholar
• Hayashi Y, Zama K, Abe E, et al. A sensitive and reproducible fluorescent-based HPLC assay to measure the activity of acid as well as neutral β-glucocerebrosidases. Anal Biochem. 2015;10(1):122–129.
   Web of Science ®Google Scholar
• El-Sayed M-I. Effects of portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol. 2011;137(1):643–651.
   PubMed Web of Science ®Google Scholar
• Yang Z, Liu C, Xiang L, et al. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother Res. 2009;23(7):1032–1035.
   PubMed Web of Science ®Google Scholar
• Iranshahy M, Javadi B, Iranshahi M, et al. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol. 2017;205:158–172.
   PubMed Web of Science ®Google Scholar
• Lee AS, Lee YJ, Lee SM, et al. Portulaca oleracea ameliorates diabetic vascular inflammation and endothelial dysfunction in db/db mice. Evid Based Complement Alternat Med. 2012;2012.
   Web of Science ®Google Scholar
• Gong F, Li F, Zhang L, et al. Hypoglycemic effects of crude polysaccharide from purslane. Int J Mol Sci. 2009;10(3):880–888.
   Web of Science ®Google Scholar
• Ramadan BK, Schaalan MF, Tolba AM. Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. BMC Complement Altern Med. 2017;17(1):37.
   PubMed Web of Science ®Google Scholar
• Lei X, Barbour SE, Ramanadham S. Group VIA Ca2+-independent phospholipase A2 (iPLA2β) and its role in β-cell programmed cell death. Biochimie. 2010;92(6):627–637.
   Web of Science ®Google Scholar
• Jakuš V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004;53(2):131–142.
   PubMed Web of Science ®Google Scholar
• Goh S-Y, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93(4):1143–1152.
   PubMed Web of Science ®Google Scholar
• Yabu T, Shiba H, Shibasaki Y, et al. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling. Cell Death Differ. 2015;22(2):258–273.
   Web of Science ®Google Scholar
• Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2002;1585(2–3):114–125.
   PubMed Web of Science ®Google Scholar
• Boslem E, Meikle PJ, Biden TJ. Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction. Islets. 2012;4(3):177–187.
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T. beta-cell apoptosis: stimuli and signaling. Diabetes. 2001;50(suppl 1):S58.
   PubMed Web of Science ®Google Scholar
• Patrick RC, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. 2004;206(2):169–180.
   Web of Science ®Google Scholar